Skip to content

Modification to Fidis Vasculitis, Model MX007

by Biomedical Diagnostics (Bmd) SA

510(k) K070458

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK070458 Date21 Dec 2007ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MOB
Device Class
Class II
Regulation
21 CFR Part 866.5660
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Modification to Fidis Vasculitis, Model MX007 is a test system for Antineutrophil Cytoplasmic Antibodies (ANCA). It is used in conjunction with clinical findings and other laboratory tests to aid in the diagnosis of various primary systemic small vessel vasculitis.

This device is manufactured by Biomedical Diagnostics (BMD) SA and received FDA 510(k) clearance with K number K070458 on 2007-12-21. It is classified under product code MOB and regulation number 866.5660, with a medical specialty in Immunology. The device is intended for use in laboratory settings and is supplied as part of the FIDIS system.

Other devices from Biomedical Diagnostics (Bmd) SA

See all devices from Biomedical Diagnostics (Bmd) SA →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Modification to Fidis Vasculitis, Model MX007 used for?

    This test system is designed for detecting Antineutrophil Cytoplasmic Antibodies (ANCA) and is used in conjunction with clinical findings and other laboratory tests to aid in the diagnosis of various primary systemic small vessel vasculitis conditions.

  • How is the Modification to Fidis Vasculitis, Model MX007 supplied?

    The device is supplied as part of the FIDIS system and is intended for use in laboratory settings. It is manufactured by Biomedical Diagnostics (BMD) SA and requires integration with their testing platform for proper functionality.

  • What is the regulatory status of the Modification to Fidis Vasculitis, Model MX007?

    This device received FDA 510(k) clearance with K number K070458 on December 21, 2007. It is classified under product code MOB and regulation number 866.5660, with a medical specialty in Immunology, indicating it meets FDA safety and effectiveness requirements for its intended use.

  • Is the Modification to Fidis Vasculitis, Model MX007 a single-use or reusable device?

    The device data does not specify whether this particular modification is single-use or reusable. As a test system component, it may be designed for either use pattern depending on the specific configuration of the FIDIS system it integrates with.